Home / Import refusals / SCS-4005009-3/10002/1

FDA Import Refusal SCS-4005009-3/10002/1 — BOEHRINGER INGELHEIM

BOEHRINGER INGELHEIM — FEI 3027355614

The FDA refused shipment SCS-4005009-3/10002/1 from BOEHRINGER INGELHEIM (India) on October 9, 2025. The refused product falls under Drugs and Biologics — EMPAGLIFLOZIN (ANTI-DIABETIC). Cited charges: 118,3280 This firm has 5 or more other import refusals on record.

Refusal Details

Date
October 9, 2025
Country
India
Product Category
Drugs and Biologics
Product Code
61PCA73 EMPAGLIFLOZIN (ANTI-DIABETIC)
Charges
118,3280

Other import refusals

  • 1FX-7755824-4/10002/1 (Mon May 18 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 1FX-5347745-0/30002/1 (Sat May 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-5133554-8/30002/1 (Tue Nov 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • SCS-4882374-9/10003/1 (Mon Oct 27 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • SCS-4679052-8/10002/1 (Fri Oct 24 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources